Title |
The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy
|
---|---|
Published in |
Biochimica et Biophysica Acta (BBA), November 2014
|
DOI | 10.1016/j.bbagrm.2014.10.007 |
Pubmed ID | |
Authors |
Simone J. Woods, Katherine M. Hannan, Richard B. Pearson, Ross D. Hannan |
Abstract |
Recent studies have highlighted the fundamental role that key oncogenes such as MYC, RAS and PI3K occupy in driving RNA Polymerase I transcription in the nucleolus. In addition to maintaining essential levels of protein synthesis, hyperactivated ribosome biogenesis and nucleolar function plays a central role in suppressing p53 activation in response to oncogenic stress. Consequently, disruption of ribosome biogenesis by agents such as the small molecule inhibitor of RNA Polymerase I transcription, CX-5461, has shown unexpected, potent, and selective effects in killing tumour cells via disruption of nucleolar function leading to activation of p53, independent of DNA damage. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Iran, Islamic Republic of | 1 | 25% |
Thailand | 1 | 25% |
United States | 1 | 25% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 2 | 50% |
Members of the public | 2 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 2 | 1% |
United States | 1 | <1% |
Unknown | 154 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 33 | 21% |
Student > Bachelor | 25 | 16% |
Researcher | 20 | 13% |
Student > Master | 20 | 13% |
Student > Doctoral Student | 8 | 5% |
Other | 20 | 13% |
Unknown | 31 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 51 | 32% |
Agricultural and Biological Sciences | 35 | 22% |
Medicine and Dentistry | 15 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
Chemistry | 7 | 4% |
Other | 7 | 4% |
Unknown | 35 | 22% |